WO2002097127A3 - Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease - Google Patents

Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease Download PDF

Info

Publication number
WO2002097127A3
WO2002097127A3 PCT/EP2002/005835 EP0205835W WO02097127A3 WO 2002097127 A3 WO2002097127 A3 WO 2002097127A3 EP 0205835 W EP0205835 W EP 0205835W WO 02097127 A3 WO02097127 A3 WO 02097127A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
prognosis
prediction
diagnosis
prevention
Prior art date
Application number
PCT/EP2002/005835
Other languages
French (fr)
Other versions
WO2002097127A2 (en
Inventor
Nadja Oellers
Mathias Gehrmann
Harald Kallabis
Roderick Hall
Thomas Schulze
Claus Kroegel
Original Assignee
Bayer Ag
Nadja Oellers
Mathias Gehrmann
Harald Kallabis
Roderick Hall
Thomas Schulze
Claus Kroegel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Nadja Oellers, Mathias Gehrmann, Harald Kallabis, Roderick Hall, Thomas Schulze, Claus Kroegel filed Critical Bayer Ag
Priority to AU2002314114A priority Critical patent/AU2002314114A1/en
Publication of WO2002097127A2 publication Critical patent/WO2002097127A2/en
Publication of WO2002097127A3 publication Critical patent/WO2002097127A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

Genes that are differentially expressed in lung tissue of COPD patients versus lungs of normal people are disclosed. The genes provide novel methods for the prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease.
PCT/EP2002/005835 2001-05-31 2002-05-28 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease WO2002097127A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002314114A AU2002314114A1 (en) 2001-05-31 2002-05-28 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113266.1A GB0113266D0 (en) 2001-05-31 2001-05-31 Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease
GB0113266.1 2001-05-31

Publications (2)

Publication Number Publication Date
WO2002097127A2 WO2002097127A2 (en) 2002-12-05
WO2002097127A3 true WO2002097127A3 (en) 2003-08-21

Family

ID=9915652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/005835 WO2002097127A2 (en) 2001-05-31 2002-05-28 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease

Country Status (3)

Country Link
AU (1) AU2002314114A1 (en)
GB (1) GB0113266D0 (en)
WO (1) WO2002097127A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006248201A1 (en) 2005-05-19 2006-11-23 Synergenz Bioscience Limited Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
AU2006248189A1 (en) 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
CA2636990A1 (en) * 2006-01-13 2007-07-26 Battelle Memorial Institute Animal model for assessing copd-related diseases
US20100119474A1 (en) * 2007-03-06 2010-05-13 Cornell University Chronic obstructive pulmonary disease susceptibility and related compositions and methods
WO2015036599A1 (en) * 2013-09-16 2015-03-19 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Mutant calreticulin for the diagnosis of myeloid malignancies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854191A2 (en) * 1997-01-02 1998-07-22 Smithkline Beecham Corporation Human cardiac/brain tolloid-like protein
US5955314A (en) * 1996-11-08 1999-09-21 Incyte Pharmaceuticals, Inc. Regulator of cell signaling
WO2000055174A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Human prostate cancer associated gene sequences and polypeptides
EP1043406A1 (en) * 1997-12-16 2000-10-11 Teijin Limited Analysis of predisposition based on human airway tripsin protease gene polymorphism

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955314A (en) * 1996-11-08 1999-09-21 Incyte Pharmaceuticals, Inc. Regulator of cell signaling
EP0854191A2 (en) * 1997-01-02 1998-07-22 Smithkline Beecham Corporation Human cardiac/brain tolloid-like protein
EP1043406A1 (en) * 1997-12-16 2000-10-11 Teijin Limited Analysis of predisposition based on human airway tripsin protease gene polymorphism
WO2000055174A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Human prostate cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
WO2002097127A2 (en) 2002-12-05
GB0113266D0 (en) 2001-07-25
AU2002314114A1 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
WO2003031650A3 (en) Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
WO2003090695A3 (en) TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
EP1765388B8 (en) Combination therapy for preventing or treating alzheimer's disease, and kit therefor
WO2003101283A3 (en) Diagnostics markers for lung cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2005062972A3 (en) Treatment of cancer with novel anti-il 13 monoclonal antibodies
EP1365034A3 (en) Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
WO2003013537A3 (en) Irinotecan for treatment of cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2005046614A3 (en) System for treating and preventing breast cancer
WO2002097127A3 (en) Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
WO2005030266A3 (en) Optical imaging of colorectal cancer
EP1589980A4 (en) Methods of diagnosis and treatment of interstitial lung disease
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2004074436A3 (en) Methods of use of a gpcr in the diagnosis and treatment of colon and lung cancer
AU2003232022A1 (en) USE OF PARATHYROID HORMONE-RELATED PROTEIN (PTHrP) IN THE DIAGNOSIS AND TREATMENT OF CHRONIC LUNG DISEASE AND OTHER PATHOLOGIES
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2004015390A3 (en) Lung cancer target proteins and use thereof
WO1998052617A3 (en) Contrast media for imaging of lung draining lymph nodes, administered through the lungs
WO2001062925A3 (en) 103p2d6: tissue specific protein highly expressed in various cancers
AU2002340728A1 (en) Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
WO2001089550A3 (en) Use of ciliary neurotrophic factor
AU2003240326A1 (en) Eef1a2 for use in the prognosis, diagnosis and treatment of cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP